Forest Lexapro maintenance claim
Forest Lexapro receives supplemental approval for prevention of relapse following long-term treatment of major depressive disorder Aug. 29. Escitalopram longer-term efficacy data will replace data from the predecessor antidepressant Celexa (citalopram) in Lexapro's Aug. 14 approved labeling (1"The Pink Sheet" Aug. 19, p. 3). The sNDA was filed Oct. 29, seven months after the NDA was filed...
You may also be interested in...
Forest's Lexapro (escitalopram) label includes a statement of greater potency than its predecessor antidepressant Celexa (citalopram)
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.